The Disease Spectrum in Premature Infants and the Progress of Pharmacological Treatment
Journal of the Korean Medical Association
;
: 1003-1008, 2006.
Artigo
em Coreano
| WPRIM
| ID: wpr-119302
ABSTRACT
Liveborn infants delivered before 37 week of postmenstrual age or less than 2,500g of birth weight are defined as premature infants. Recently, the unprecedented progress in neonatal practice has achieved remarkable improvements in the survival of extremely premature infants. However, immature organ function and the complication of therapy still contribute to the high mortality and morbidity from a spectrum of disease especially in extremely premature, low birth weight infants; respiratory distress syndrome, chronic lung disease, necrotizing enterocolitis, intraventricular hemorrhage, nosocomial infection, and prolonged hospitalization consist of the spectrum of disease in premature infants. To achieve further progress in neonatal-perinatal practice, randomized clinical trials should be employed not just to test the effectiveness of new therapies but also to evaluate competing strategies toward evidence-based, better clinical practice.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Peso ao Nascer
/
Recém-Nascido de Baixo Peso
/
Recém-Nascido Prematuro
/
Infecção Hospitalar
/
Mortalidade
/
Enterocolite Necrosante
/
Lactente Extremamente Prematuro
/
Hemorragia
/
Hospitalização
/
Pneumopatias
Tipo de estudo:
Ensaio Clínico Controlado
/
Estudo prognóstico
Limite:
Humanos
/
Lactente
/
Recém-Nascido
Idioma:
Coreano
Revista:
Journal of the Korean Medical Association
Ano de publicação:
2006
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS